Direct thrombin inhibition: a novel approach to stroke prevention in patients with atrial fibrillation

Journal article

Open access

Peer reviewed

Mitchell S V Elkind and Ralph L Sacco

Stroke (1970), Vol.35(6), pp.1519-1522

2004-06

PMID: 15143301

Abstract

Stroke - etiology

Stroke - prevention & control

Azetidines - therapeutic use

Humans

Thrombin - antagonists & inhibitors

Atrial Fibrillation - complications

Benzylamines

Anticoagulants - therapeutic use

Aged

Randomized Controlled Trials as Topic

Warfarin - therapeutic use

url

https://doi.org/10.1161/01.STR.0000128883.89984.52View

Published (Version of record) Open

19 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.94 Cardiac Arrhythmia; 1.94.95 Atrial Fibrillation
Web Of Science research areas: Clinical Neurology; Peripheral Vascular Disease
ESI research areas: Neuroscience & Behavior

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Direct thrombin inhibition: a novel approach to stroke prevention in patients with atrial fibrillation
Creators: Mitchell S V Elkind - Department of Neurology, College of Physicians and Surgeons, Columbia University, and the Columbia University Medical Center of New York-Presbyterian Hospital, New York, USA. mse13@columbia.edu
Ralph L Sacco
Publication Details: Stroke (1970), Vol.35(6), pp.1519-1522
Publisher: United States
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Department of Neurology
Language: English
Resource Type: Journal article
PMID: 15143301
Record Identifier: 991031559248102976